Global Afamelanotide Market (2024–2032): USD 136.27M to USD 258.01M Growth at 9.1% CAGR
Global Afamelanotide Market is projected to grow from USD 136.27 million in 2024 to USD 258.01 million by 2032, registering a strong CAGR of 9.1%. Afamelanotide (SCENESSE®), the first approved treatment for EPP, enhances melanin production to improve sunlight tolerance in patients with severe phototoxic disorders. Rising awareness of rare diseases, expanding clinical trials in vitiligo and photodermatoses, and broader regulatory support are fueling market demand globally.

POV: you just gave a man a compliment

Commenting has been turned off for this post.

Global Atomizing Iron Powder Market (2025–2032): USD 971M to USD 1.234B Growth at 3.6% CAGR
Global Atomizing Iron Powder Market is experiencing steady growth, rising from USD 971 million in 2025 to USD 1.234 billion by 2032, driven by a 3.6% CAGR. Atomized iron powder—produced through high-pressure water atomization of molten iron—offers high purity, superior compressibility, excellent sintering performance, and uniform spherical particle structure, making it the preferred material in powder metallurgy, automotive components, aerospace engineering, and industrial machinery.Demand continues to increase as industries shift toward advanced manufacturing technologies, including metal injection molding (MIM), additive manufacturing, and precision-engineered parts. The market benefits from sustainability trends, as atomized iron powder supports material recycling, waste reduction, and circular economy goals. However, high production energy consumption and raw material supply chain volatility pose challenges.Asia-Pacific dominates the market due to its strong manufacturing base, while North America and Europe maintain stable demand driven by innovation, automotive production, and high-value industrial applications. Supported by technological advancements and expanding industrialization across emerging regions, the atomizing iron powder market presents significant opportunities for manufacturers, investors, and industry stakeholders.

Global ATP Tester and Consumables for Healthcare Market (2025–2032): USD 443M to USD 767M Growth at 8.1% CAGR

global ATP Tester and Consumables for Healthcare market was valued at USD 443 million in 2024 and is projected to reach USD 767 million by 2032, growing at an 8.1% CAGR. ATP testers are essential tools for real-time hygiene monitoring in hospitals, clinics, and labs. Growth is fueled by rising healthcare-associated infections (HAIs), stricter regulatory guidelines, and advancements in rapid bioluminescence detection technologies.